Show
Sort by
-
- Journal Article
- A1
- open access
The use of population pharmacokinetics to extrapolate food effects from human adults and beagle dogs to the pediatric population illustrated with paracetamol as a test case
-
Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney function
-
- Conference Paper
- C3
- open access
Extensive review of pharmacokinetic and pharmacodynamic properties of ACE-inhibitors and angiotensin receptor blockers in hypertensive children
-
- Conference Paper
- C3
- open access
Population pharmacokinetics and Bayesian estimations of lisinopril at steady state in hypertensive children with mild to moderate renal impairment
-
- Journal Article
- A1
- open access
Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases
-
- Conference Paper
- C3
- open access
Extensive review of pharmacokinetic and pharmacodynamic properties of ace-inhibitors and angiotensin receptor blockers in children with renal impairment
-
- Conference Paper
- C3
- open access
Extensive review of trial methodology investigating therapeutics ACE-inhibitors and angiotensin receptor blockers in hypertensive paediatric patients
-
Population pharmacokinetic modeling of lisinopril at steady-state in hypertensive paediatric patients with mild to moderate renal impairement
-
Bayesian population approach to determine lisinopril exposure in hypertensive paediatric patients with mild to moderate renal impairment
-
Population pharmacokinetics of lisinopril in hypertensive children with mild to moderate renal impairment